logo
  • Product
    • pHyph
    • Mode of Action
    • Medical Effect
    • Bacterial Vaginosis
    • Medical Need
  • Sustainability
  • Development
    • Clinical Evidence
    • Bacterial Vaginosis
    • The vaginal microbiome
    • Pipeline
    • Further Development
    • Technical and Biological Data
  • News
  • About us
    • Team
    • Contact
  • Svenska
  • Search

Month: December 2020

Gedea’s pHyph antibiotic-free treatment shows high cure rate and low risk of recurrence in bacterial vaginosis in published study

Gedea’s pHyph antibiotic-free treatment shows high cure rate and low risk of recurrence in bacterial vaginosis in published study

by Eva Norell

Search

Archive

  • March 2025
  • December 2024
  • November 2024
  • April 2024
  • February 2024
  • November 2023
  • September 2023
  • June 2023
  • May 2023
  • April 2023
  • December 2022
  • November 2022
  • May 2022
  • February 2022
  • December 2021
  • October 2021
  • September 2021
  • June 2021
  • March 2021
  • February 2021
  • January 2021
  • December 2020
  • November 2020
  • April 2020
  • March 2020
  • January 2020
  • December 2019
  • November 2019
  • October 2019
  • June 2019
  • May 2019
  • March 2019
  • December 2018
  • October 2018
  • September 2018
  • June 2018
  • May 2018
  • March 2018
  • December 2017
  • September 2017
  • June 2017
  • May 2017
  • April 2017
  • March 2017
  • December 2016

Gedea Biotech AB
Medicon Village
Scheeletorget 1
223 81 Lund
Sweden

Annette Säfholm, CEO
annette.safholm@gedeabiotech.com
+46 (0) 708 – 91 86 81

Privacy Policy
Cookie Policy

© 2025 Gedea Biotech. All rights reserved